Chellian R, Behnood-Rod A, Bruijnzeel A
Front Pharmacol. 2024; 15:1415219.
PMID: 39391691
PMC: 11464435.
DOI: 10.3389/fphar.2024.1415219.
Hirotsu C, Pedroni M, Berro L, Tufik S, Andersen M
Sci Rep. 2018; 8(1):13837.
PMID: 30218019
PMC: 6138689.
DOI: 10.1038/s41598-018-32276-7.
Chiamulera C, Marzo C, Balfour D
Psychopharmacology (Berl). 2016; 234(9-10):1357-1370.
PMID: 27847973
DOI: 10.1007/s00213-016-4487-3.
Harris A, Mattson C, Shelley D, Lesage M
Pharmacol Biochem Behav. 2014; 124:92-100.
PMID: 24867077
PMC: 4150835.
DOI: 10.1016/j.pbb.2014.05.012.
Quik M, Zhang D, Perez X, Bordia T
Pharmacol Ther. 2014; 144(1):50-9.
PMID: 24836728
PMC: 4149916.
DOI: 10.1016/j.pharmthera.2014.05.004.
Marshaling the evidence for greater regulation and control of tobacco products: A call for action.
Kaplan R, Orleans C, Perkins K, Pierce J
Ann Behav Med. 2013; 17(1):3-14.
PMID: 24203496
DOI: 10.1007/BF02888801.
Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine.
Levine A, Huang Y, Drisaldi B, Griffin Jr E, Pollak D, Xu S
Sci Transl Med. 2011; 3(107):107ra109.
PMID: 22049069
PMC: 4042673.
DOI: 10.1126/scitranslmed.3003062.
Mechanism-based medication development for the treatment of nicotine dependence.
Xi Z, Spiller K, Gardner E
Acta Pharmacol Sin. 2009; 30(6):723-39.
PMID: 19434058
PMC: 3713229.
DOI: 10.1038/aps.2009.46.
Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning.
Mineur Y, Brunzell D, Grady S, Lindstrom J, McIntosh J, Marks M
Genes Brain Behav. 2008; 8(3):257-66.
PMID: 19077117
PMC: 2672109.
DOI: 10.1111/j.1601-183X.2008.00468.x.
Smoking and suicide: a brief overview.
Hughes J
Drug Alcohol Depend. 2008; 98(3):169-78.
PMID: 18676099
PMC: 2585177.
DOI: 10.1016/j.drugalcdep.2008.06.003.
Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction.
Pidoplichko V, Noguchi J, Areola O, Liang Y, Peterson J, Zhang T
Learn Mem. 2004; 11(1):60-9.
PMID: 14747518
PMC: 321315.
DOI: 10.1101/lm.70004.
Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.
DESAI H, Seabolt J, Jann M
CNS Drugs. 2001; 15(6):469-94.
PMID: 11524025
DOI: 10.2165/00023210-200115060-00005.
Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.
Kempsill F, Pratt J
Br J Pharmacol. 2000; 131(5):997-1003.
PMID: 11053222
PMC: 1572401.
DOI: 10.1038/sj.bjp.0703560.
Effects of environmental conditioning on the development of nicotine sensitization: behavioral and neurochemical analysis.
Reid M, Ho L, Berger S
Psychopharmacology (Berl). 1996; 126(4):301-10.
PMID: 8878346
DOI: 10.1007/BF02247381.
Influence of training dose on nicotine discrimination in humans.
Perkins K, DAmico D, Sanders M, Grobe J, Wilson A, STILLER R
Psychopharmacology (Berl). 1996; 126(2):132-9.
PMID: 8856832
DOI: 10.1007/BF02246348.
The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.
CLARKE P, Chaudieu I, Boksa P, Quik M, Esplin B, capek R
Br J Pharmacol. 1994; 111(2):397-405.
PMID: 7911713
PMC: 1909961.
DOI: 10.1111/j.1476-5381.1994.tb14748.x.
Effects of subacute administration of methamphetamine and nicotine on locomotor activity in transgenic mice expressing the human tyrosine hydroxylase gene.
Nabeshima T, Itoh A, Kobayashi K, Morita S, Mizuguchi T, Sawada H
J Neural Transm Gen Sect. 1994; 97(1):41-9.
PMID: 7888148
DOI: 10.1007/BF01277961.
Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.
Benwell M, Balfour D, Lucchi H
Psychopharmacology (Berl). 1993; 112(4):467-74.
PMID: 7871059
DOI: 10.1007/BF02244896.
Is the dopaminergic system involved in the central effects of nicotine in mice?.
Damaj M, Martin B
Psychopharmacology (Berl). 1993; 111(1):106-8.
PMID: 7870924
DOI: 10.1007/BF02257415.
Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence.
Pomerleau O
Behav Genet. 1995; 25(2):161-77.
PMID: 7733857
DOI: 10.1007/BF02196925.
